Research On Overall Cost Leadership Strategy Of RYZY

The competitive situation of domestic pharmaceutical enterprises intensified in recent years,which makes the environment for survival and development of pharmaceutical enterprises are facing opportunities and challenges,although there are great development opportunities,but also faces many unfavorable factors.With the trend of the global pharmaceutical market integration and the price of medicine cut gradually obvious,and the price of raw materials,human resources and land continue to rise,the compression of the domestic pharmaceutical enterprises the space of profit,the living space of Pharmaceutical companies is shrinking.At present,the pharmaceutical companies like RYZY have achieved good results in the past,but because of the lack of effective planning and strategy,they will face more intense market competition.It is one of the most urgent tasks for RYZY that how to improve the current competitive situation and how to achieve sustainable development in the increasingly fierce market competition.Based on the theoretical method of production characteristic of pharmacy enterprise products and the strategy of low cost competition,from the analysis of the market environment and the development trend of the pharmaceutical industry prospects,and then use Porter's "Five Forces Model" to analyze the pharmaceutical industry competition,on the basis of this,use the SWOT analysis model,determine the strategic choice of RYZY company.Through the above analysis of the low cost strategy formulated to evaluate the RYZY,focuses on the detailed measures of RYZY company's competitive strategy,to explore the status of implementation of RYZY low cost strategy and its effect,and provide the improvement strategy and coordination strategy.Low cost strategy as an important part of pharmaceutical enterprise development strategy,this paper tries to help RYZY to develop low cost strategy and specific measures,and formulate the relevant security strategy,to the enterprise operation to give clear guidance,so as to achieve the strategic goal of the enterprise.It also provides a reference for the same type of domestic pharmaceutical companies to develop strategies to enhance the competitiveness of China's pharmaceutical industry,to promote its bigger and stronger to do their part.